Warning letter
Nomax Inc: warning letter of Dec 15, 2016
FDA warning letter 512566 · Kansas City District Office
Key facts
| Reference number | 512566 |
|---|---|
| Company | Nomax Inc |
| Subject | Medical Devices/Adulterated/Quality System Regulation (QSR) |
| Issue date | Dec 15, 2016 |
| Posted date | Dec 26, 2016 |
| Issuing office | Kansas City District Office |
| Product type | Devices |
| CFR sections cited | 820 |
| Inspection city | Saint Louis |
| Inspection ZIP | 63123 |
| Inspection start date | Oct 18, 2016 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: